Literature DB >> 15124687

Core binding factor acute myeloid leukemia. Cancer and Leukemia Group B (CALGB) Study 8461.

C D Bloomfield1, A S Ruppert, K Mrózek, J E Kolitz, J O Moore, R J Mayer, C G Edwards, L J Sterling, J W Vardiman, A J Carroll, M J Pettenati, J Stamberg, J C Byrd, G Marcucci, R A Larson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15124687     DOI： 10.1007/s00277-004-0850-2

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  5 in total

1.  Overexpression and knockout of miR-126 both promote leukemogenesis.

Authors:  Zejuan Li; Ping Chen; Rui Su; Yuanyuan Li; Chao Hu; Yungui Wang; Stephen Arnovitz; Miao He; Sandeep Gurbuxani; Zhixiang Zuo; Abdel G Elkahloun; Shenglai Li; Hengyou Weng; Hao Huang; Mary Beth Neilly; Shusheng Wang; Eric N Olson; Richard A Larson; Michelle M Le Beau; Jiwang Zhang; Xi Jiang; Minjie Wei; Jie Jin; Paul P Liu; Jianjun Chen
Journal:  Blood       Date:  2015-09-11       Impact factor: 22.113

2.  Distinct microRNA expression profiles in acute myeloid leukemia with common translocations.

Authors:  Zejuan Li; Jun Lu; Miao Sun; Shuangli Mi; Hao Zhang; Roger T Luo; Ping Chen; Yungui Wang; Ming Yan; Zhijian Qian; Mary Beth Neilly; Jie Jin; Yanming Zhang; Stefan K Bohlander; Dong-Er Zhang; Richard A Larson; Michelle M Le Beau; Michael J Thirman; Todd R Golub; Janet D Rowley; Jianjun Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-01       Impact factor: 11.205

3.  Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Intermediate-Risk Acute Myeloid Leukemia Adult Patients in First Complete Remission: A Meta-Analysis of Prospective Studies.

Authors:  Dandan Li; Li Wang; Honghu Zhu; Liping Dou; Daihong Liu; Lin Fu; Cong Ma; Xuebin Ma; Yushi Yao; Lei Zhou; Qian Wang; Lijun Wang; Yu Zhao; Yu Jing; Lili Wang; Yonghui Li; Li Yu
Journal:  PLoS One       Date:  2015-07-21       Impact factor: 3.240

4.  A targeted next-generation sequencing in the molecular risk stratification of adult acute myeloid leukemia: implications for clinical practice.

Authors:  Po-Han Lin; Huei-Ying Li; Sheng-Chih Fan; Tzu-Hang Yuan; Ming Chen; Yu-Hua Hsu; Yu-Hsuan Yang; Long-Yuan Li; Su-Peng Yeh; Li-Yuan Bai; Yu-Min Liao; Chen-Yuan Lin; Ching-Yun Hsieh; Ching-Chan Lin; Che-Hung Lin; Ming-Yu Lien; Tzu-Ting Chen; Yen-Hsuan Ni; Chang-Fang Chiu
Journal:  Cancer Med       Date:  2017-01-10       Impact factor: 4.452

Review 5.  Targeting binding partners of the CBFβ-SMMHC fusion protein for the treatment of inversion 16 acute myeloid leukemia.

Authors:  Lisa Richter; Yiqian Wang; R Katherine Hyde
Journal:  Oncotarget       Date:  2016-10-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.